
I.V.
Ther
apy
Dem
ystified
I'a<""1>
of
modified
PRBC.
ore
001
only .pecially prepared.
but
they are
.ho
"'ued
as
.och.oo
tlpic.lll
or.
prepared.oo
di.tributed in donut_shaped
in""ve""".
b.gs
in
order to
mal.
it
vi.ually apparent that they
Iu,..,
been modilied."'"
PRBCs
>r.
imodiated with
gamma
..
y.
to
inactivat. dono< lymphoc),te. tllat
c.n
c
.....
graft_"""".
_
"""t
di"'
....
(GVHD).
Patien"
"'ho
are . t ri.k
f<4"
trm<fu.ioo_
rel.ted
GVHD.Dd
f<4"
"'hom
imodiated PRBC. are indicated inrlude those ,,'ho
mve
hod
bone
marrow
1"''''p
l
",,''
.Dd
".m
cell
t""",
pI""I>.oo those "'i
th
Hodgki
lIS
0.-
oon_Hodgkins lymphoma.
In
addit;oo. I"'tienl>
"'ho
reooi,.., donated blood from
family
"",mbe
..
are
at iocreased ri,k
f<4"
tr.lfl.fu<;oo~i.ted
GVHD for
re
.......
that are not entirely d
.....
A
••
ron""'lIXOC<.
blood
donated
fo.-
use
.mong
hmi
ly
memhcn
.hould
bo
imodi.ted proph),loctically prior to odmini
..
"'
t
ion."
PRBCs are ", ••
hod
in ,
..
rile
..
line to ",move pl •• m. protein
••
Dd
cellular debris
that are commonly impl
ic.ted
in tr.lfl.fu.;oo_rel.ted . Ilergic reoct;oo •. W
..
hing
of
PRBc.
i.
indic.ted
f<4"
I"'ti.nl> who
Iu,..,
hod
•
J>reVioou
.Ilergic reoct;oo
to.
blood
compooent."
u,u
k
oclte
. may he reduced from PRBC. throogh
fi
ltering
.00
other
method! for pat",nl> woo
1Ia,..,
hod
a previ"'" febril.
"""lIemol).ic
(FNH) reoct;oo
to blood trm<fu';on •.
Patien"
woo hove
hod
mu
ltiple blood
trm.fu.ioIu
may bo
con,idered c.ooi<l2l
••
f<4"
leu koc),te_redoced PRBC"
.1..,
refemod to
..
ku/:o<)',,-
poor
PRBe.
, to
pre,'ent.
febrile "'''''tiOll from
occumng,"
PRBCs may he .pecially """",ned
f<4"
CMV
.•
virus that is commonly oarried in
• dormant
"ate
by
many oJ
ula,
However.
I"'t",n"
woo are
.ither
immu oosuppre,sed
(e,
g
..
pat
",n"
wi
th
active neoplasm.
Of
patient> woo
h.ve
~i,'od
organ
",ilI'pl"",,)
0.-
woo h
..
,.
immature immune
sy.tems
(e,g
..
infants
YOllnger
than 4 ,,'eeko
of
.ge)
and woo
haY<
not been
..
po><"<!
previously
10
CMV
are at
ri.
k
fo.-
CMV
_related
..
psis, Therefore. the"" potiont. sboold recei,'e
PRBc.
that
....
e been
",....,ned.oo
deemed
dear
of
CMV
."
FRE
S
H-FR
O
ZEN
PLA
S
MA
.-
...
. h·r
........
pl
as
ma (FFP)
i.
the fr:octioo.ted pla
.m.
ponion
of.
unit
of
do
...
ted
blood that
i.
""ntrifugoo until it ront.ain. no e,),throcyte •. leukocytes.
0<
pl
.tele"
.
FFP may
he
",,,ed
,-,foly
in
its
fro",n
.U
te
fo<
at
le
..
t I y.ar.
Onr.
thawed. it
must he administered within 6-2-1
hou".
FFP
ron"in.
many importont
doning
facto.-.. i
ndud
ing faclor
V.
foctor VIII. .Dd fibrinog.n.
Boc.u,"
it
i.
rich in
doning
facto.-.. the moot
rommoo
indication.
fo.-
trm.fusion
of
FFP
i.
to COIT«t "",,ut.
cnagulopathi
••
, inrluding
di»<min
. ted i
ntra,'""u
l
.,
coagulation (DlC). to
correct
dotting
defioienci
..
bee""""
of
liver di
...
",.
and to ",..-orse the <ff..,,,
of
the
.nticoagu
l
""
t warfarin (COIImodin).
P>1
i
ents
"'00
take
..
'.rfarin
.00
"'00
""'y
""Iuire FFP i
ndud.
those "'hose
dotting
time
••
re
1000g.r
th."
n""e.>Or)' to